Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

This study is ongoing, but not recruiting participants.

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00186381

Purpose

Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.

Condition	Intervention	Phase
Leukemia, Myelocytic, Acute	Procedure: high dose chemotherapy then autologous hematopoietic cell transplant	Phase II

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title:	Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

Further study details as provided by Stanford University:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	200
Study Start Date:	November 1995

Detailed Description:

To use high dose chemotherapy with autologous stem cell rescue to try to increase the chance of long term control and cure of the disease.

Eligibility

Criteria

Inclusion Criteria:- must be in remission

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00186381

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

Laura Johnston

Stanford University

More Information

Study ID Numbers:	BMT8N, 77045, BMT8N, NCT00186381
Study First Received:	September 13, 2005
Last Updated:	October 23, 2008
ClinicalTrials.gov Identifier:	NCT00186381
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Leukemia
Acute myelogenous leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Acute myelocytic leukemia

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Histologic Type

ClinicalTrials.gov processed this record on January 15, 2009